GFAP and stroke disorder: When the first dose of HFI419 was delayed to 6 h post stroke, treatment significantly increased CD11b counts in the cortical penumbra (Supplementary Fig. 2I) however no differences were detected in the number of GFAP positive cells between the drug treated and vehicle treated groups in any brain region (Supplementary Fig. 2D–F).